NASDAQ:KPTI - Karyopharm Therapeutics Inc.
$9.05
 $0.24
+2.72%
2:00PM EDT
2019-02-15
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. It has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. The Company's lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications. Oral selinexor is being evaluated in multiple later-phase clinical trials in patients with relapsed and/or refractory hematological and solid tumor malignancies. Its lead drug candidate, oral selinexor (KPT-330), as well as verdinexor (KPT-335), KPT-8602 and KPT-9274 are in clinical development. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KPTI     avg for
industry  
  avg for
sector  
42 stocks weight:  26. 29   0. 00   0. 00  
42 stocks rank:  3. 45 K 1. 86 K 1. 09 K
# analyst opinions:  10. 00   14. 92   14. 43  
mean recommendation:  1. 60   1. 91   1. 93  

quick ratio:  4. 97   5. 37   1. 81  
current ratio:  5. 09   5. 69   2. 19  

target price low:  9. 55   88. 97   117. 82  
target price avg:  15. 00   115. 19   141. 96  
target price high:  23. 90   143. 40   163. 16  
1-yr high:  21. 18   124. 30   142. 77  
last close:  8. 81   101. 85   127. 84  
50-day avg:  9. 38   98. 27   122. 46  
200-day avg:  14. 62   99. 72   122. 70  
1-yr low:  8. 20   78. 19   100. 16  
volume:  2. 32 M 2. 38 M 4. 64 M
50-day avg volume:  707. 89 K 3. 31 M 4. 94 M
200-day avg volume:  730. 44 K 3. 23 M 4. 28 M

1-day return:  -3. 82 % 0. 22 % 0. 48 %
this week return:  0. 11 % 1. 77 % 2. 01 %
12-wk return:  -16. 18 % 6. 56 % 3. 33 %
52-wk return:  -39. 17 % -2. 23 % 14. 35 %

enterprise value (EV):  316. 53 M 55. 17 B 104. 51 B
market cap:  534. 86 M 49. 01 B 96. 46 B
EBITDA:  -161. 16 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 96   -91. 79   2. 29  
enterprise/revenue (EV/R):  10. 00   29. 84   23. 39  
total revenue:  31. 66 M 11. 28 B 40. 22 B
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -159. 24 M 2. 37 B 3. 58 B

shares outstanding:  60. 71 M 607. 99 M 1. 22 B
shares:  42. 23 M 605. 53 M 1. 15 B
shares short:  5. 97 M 11. 62 M 12. 55 M
shares short prior month:  6. 08 M 11. 95 M 13. 44 M
short ratio:  10. 71   4. 82   3. 10  
short % of float:  18. 97 % 6. 19 % 2. 82 %
total cash/share:  3. 41   12. 02   11. 46  
total cash:  206. 77 M 7. 41 B 7. 37 B
free cash flow:  -66. 01 M 95. 99 M 2. 04 B
operating cash flow:  -116. 48 M 164. 74 M 3. 04 B

book value:  2. 82   14. 43   28. 26  
price/book:  3. 12   -1. 57   -2. 97  
gross profits:  -105. 67 M 8. 28 B 18. 09 B
operating margins:  -511. 24 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  -20. 08 % --- ---
1-yr mean volatility:  -0. 12 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 96   3. 03   4. 09  
forward EPS:  -3. 26   4. 33   6. 99  
P/E:  -2. 97   6. 11   26. 91  
forward P/E:  -2. 69   8. 38   10. 48  
PE/G:  0. 16   0. 37   5. 61  
growth:  -18. 95 % 683. 72 % 104. 79 %
earnings high:  -0. 53   1. 27   1. 66  
earnings avg:  -0. 85   1. 01   1. 53  
earnings low:  -1. 01   0. 76   1. 40  
revenue high:  2. 46 M 2. 86 B 11. 19 B
revenue avg:  450. 00 K 2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -52. 73 % -3. 27 % 3. 81 %
return on equity:  -101. 99 % 107. 48 % 27. 82 %
revenue/share:  0. 59   14. 68   59. 83  

beta (1yr vs S&P500):  2. 19   1. 21   0. 93  
sharpe (1yr):  -0. 49   0. 06   0. 98  

held % insiders:  19. 75 % 6. 46 % 3. 21 %
held % institutions:  87. 80 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : KPTI
.    + 0.006 =         0.006 :: INITIAL WEIGHT
.   + 189.48 =       189.486 :: inverse volume-to-price addition
.  + 333.797 =       523.284 :: spline projection addition
.  - 148.413 =       374.871 :: poor performance penalty
.    x 0.766 =       287.233 :: one-year gains+dividend factor
.    x 2.957 =       849.303 :: 13 weeks' performance factor
.    x 1.492 =      1267.575 :: industry recommendation factor
.    x 2.982 =      3780.502 :: symbol recommendation factor
.    x 1.335 =      5047.217 :: EV/R factor
.    x 0.995 =      5020.605 :: return on assets factor
.     x 0.99 =      4969.399 :: return on equity factor
.    x 2.894 =     14381.399 :: current ratio factor
.    x 1.119 =     16089.409 :: quick ratio factor
.    x 1.046 =     16823.788 :: short ratio factor
.    x 2.031 =     34173.171 :: price-to-book factor
.    x 2.158 =     73747.278 :: P/E weight
.    x 1.589 =    117171.451 :: PE/G factor
.     x 1.46 =    171039.485 :: beta factor
.    x 0.488 =     83473.753 :: sharpe factor
.    x 1.291 =    107787.128 :: target low factor
.    x 1.279 =    137903.525 :: target mean factor
.    x 1.131 =    155951.648 :: target high factor
.    x 1.066 =    166184.073 :: industry 12-weeks return
.    x 0.978 =    162519.016 :: "drift" penalty 4 days ago
.    x 0.938 =    152472.496 :: "drift" penalty 5 days ago
.    x 0.998 =    152186.937 :: overall "drift" factor
.    x 0.999 =    152060.637 :: largest single-day jump factor
.    x 0.119 =      18167.34 :: low price factor
.      x 1.0 =      18168.56 :: factor hist industry gain for week 06
.   cubeRoot =        26.289 :: reduced for readability
.                     26.289 :: FINAL WEIGHT for NASDAQ:KPTI


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org